Biology Reference
In-Depth Information
13. Chi SL, Pizzo SV. (2006) Angiostatin is directly cytotoxic to tumor cells at low extracellu-
lar pH: a mechanism dependent on cell surface-associated ATP synthase. Cancer Res 66(2):
875-82.
14. Chi SL, Pizzo SV. (2006) Cell surface F1Fo ATP synthase: a new paradigm? Ann Med
38(6):429-38.
15. Chi SL, Wahl ML, Mowery YM, Shan S, Mukhopadhyay S, Hilderbrand SC, Kenan DJ, Lipes
BD, Johnson CE, Marusich MF, Capaldi RA, Dewhirst MW, Pizzo SV. (2007) Angiostatin-
like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase. Cancer
Res 67(10):4716-24.
16. Das B, Mondragon MO, Sadeghian M, Hatcher VB, Norin AJ. (1994) A novel ligand in
lymphocyte-mediated cytotoxicity: expression of the beta subunit of H
+
transporting ATP
synthase on the surface of tumor cell lines. J Exp Med 180(1):273-81.
17. Fessenden-Raden JM. (1972) Purification and properties of a new coupling factor required for
oxidative phosphorylation in silicotungstate-treated submitochondrial particles. J Biol Chem
247(8):2351-7.
18. Gerasimovskaya EV, Woodward HN, Tucker DA, Stenmark KR. (2008) Extracellular ATP is
a pro-angiogenic factor for pulmonary artery vasa vasorum endothelial cells. Angiogenesis
11(2):169-82.
19. Hahn C, Schwartz MA. (2009) Mechanotransduction in vascular physiology and atherogene-
sis. Nat Rev Mol Cell Biol 10(1):53-62.
20. Hassessian H, Bodin P, Burnstock G. (1993) Blockade by glibenclamide of the flow-evoked
endothelial release of ATP that contributes to vasodilatation in the pulmonary vascular bed of
the rat. Br J Pharmacol 109(2):466-72.
21. Kao J, Houck K, Fan Y, Haehnel I, Libutti SK, Kayton ML, Grikscheit T, Chabot J, Nowygrod
R, Greenberg S, et al. (1994) Characterization of a novel tumor-derived cytokine. Endothelial-
monocyte activating polypeptide II. J Biol Chem 269(40):25106-19.
22. Komi Y, Ohno O, Suzuki Y, Shimamura M, Shimokado K, Umezawa K, Kojima S.
(2007) Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with
sangivamycin. Jpn J Clin Oncol 37(11):867-73.
23. Loomis CR, Bell RM. (1988) Sangivamycin, a nucleoside analogue, is a potent inhibitor of
protein kinase C. J Biol Chem 263(4):1682-92.
24. Martinez LO, Jacquet S, Esteve JP, Rolland C, Cabezon E, Champagne E, Pineau T,
Georgeaud V, Walker JE, Terce F, Collet X, Perret B, Barbaras R. (2003) Ectopic beta-
chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature
421(6918):75-9.
25. Moser TL, Kenan DJ, Ashley TA, Roy JA, Goodman MD, Misra UK, Cheek DJ, Pizzo SV.
(2001) Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited
by angiostatin. Proc Natl Acad Sci USA 98(12):6656-61.
26. Moser TL, Stack MS, Asplin I, Enghild JJ, Hojrup P, Everitt L, Hubchak S, Schnaper HW,
Pizzo SV. (1999) Angiostatin binds ATP synthase on the surface of human endothelial cells.
Proc Natl Acad Sci USA 96(6):2811-6.
27. O
Reilly MS, Holmgren L, Chen C, Folkman J. (1996) Angiostatin induces and sustains
dormancy of human primary tumors in mice. Nat Med 2(6):689-92.
28. O
Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y,
Sage EH, Folkman J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the
suppression of metastases by a Lewis lung carcinoma. Cell 79(2):315-28.
29. Ohno O, Shima Y, Ikeda Y, Kondo SI, Kato K, Toi M, Umezawa K. (2001) Selective growth
inhibition by sangivamycin of human umbilical vein endothelial cells. Int J Oncol 18(5):
1009-15.
30. Osada H, Sonoda T, Tsunoda K, Isono K. (1989) A new biological role of sangivamycin;
inhibition of protein kinases. J Antibiot (Tokyo) 42(1):102-6.
31. Osanai T, Kamada T, Fujiwara N, Katoh T, Takahashi K, Kimura M, Satoh K, Magota K,
Kodama S, Tanaka T, Okumura K. (1998) A novel inhibitory effect on prostacyclin synthesis
Search WWH ::
Custom Search